Literature DB >> 20145921

SPECT neuroimaging and neuropsychological functions in different stages of Parkinson's disease.

Anna Paschali1, Lambros Messinis, Odysseas Kargiotis, Velissarios Lakiotis, Zinovia Kefalopoulou, Costantinos Constantoyannis, Panagiotis Papathanasopoulos, Pavlos Vassilakos.   

Abstract

PURPOSE: The present study investigated differences and associations between cortical perfusion, nigrostriatal dopamine pathway and neuropsychological functions in different stages of Parkinson's disease (PD).
METHODS: We recruited 53 non-demented PD patients divided into four groups according to the Hoehn and Yahr (HY) staging system and 20 healthy controls who were used in the comparison of the neuropsychological findings. Each patient underwent two separate brain single photon emission computed tomography (SPECT) studies (perfusion and dopamine transporter binding) as well as neuropsychological evaluation. Perfusion images of each patient were quantified and compared with a normative database provided by the NeuroGam software manufacturers. Mean values obtained from the cortical areas and neuropsychological measures in the different groups were also compared by analysis of covariance (ANCOVA) controlling for disease duration and educational level.
RESULTS: We found cognitive deficits especially in the late PD stages (HY 3, 4 and 5) compared to the early stages (HY 1 and 2) and associations between cognitive decrements and cortical perfusion deterioration mainly in the frontal and posterior cortical areas. Compared with controls, PD patients showed impairments of cognition and cerebral perfusion that increased with clinical severity. Furthermore, we found a significant correlation between the performance on the phonemic fluency task and regional cerebral blood flow (rCBF) in the left frontal lobe. Dopamine transporter binding in the left caudate nucleus significantly correlated with blood flow in the left dorsolateral prefrontal cortex (DLPFC), but not with measures of executive functions.
CONCLUSION: There are significant cognitive and perfusion deficits associated with PD progression, implying a multifactorial neurodegeneration process apart from dopamine depletion in the substantia nigra pars compacta (SNc).

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20145921     DOI: 10.1007/s00259-010-1381-9

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  52 in total

1.  Basal ganglia functional connectivity based on a meta-analysis of 126 positron emission tomography and functional magnetic resonance imaging publications.

Authors:  Ronald B Postuma; Alain Dagher
Journal:  Cereb Cortex       Date:  2005-12-22       Impact factor: 5.357

Review 2.  Neuropsychological aspects of Parkinson's disease.

Authors:  S A Raskin; J C Borod; J Tweedy
Journal:  Neuropsychol Rev       Date:  1990-09       Impact factor: 7.444

3.  Beck Depression Inventory-II items associated with self-reported symptoms of ADHD in adult psychiatric outpatients.

Authors:  Robert A Steer; William F Ranieri; Geetha Kumar; Aaron T Beck
Journal:  J Pers Assess       Date:  2003-02

4.  Regional cerebral blood flow in Parkinson's disease as an indicator of cognitive impairment.

Authors:  Mirosława Derejko; Jarosław Sławek; Dariusz Wieczorek; Bogna Brockhuis; Mirosława Dubaniewicz; Piotr Lass
Journal:  Nucl Med Commun       Date:  2006-12       Impact factor: 1.690

5.  Relationships between striatal dopamine denervation and frontal executive tests in Parkinson's disease.

Authors:  R M Marié; L Barré; B Dupuy; F Viader; G Defer; J C Baron
Journal:  Neurosci Lett       Date:  1999-01-29       Impact factor: 3.046

6.  Changes in network activity with the progression of Parkinson's disease.

Authors:  Chaorui Huang; Chengke Tang; Andrew Feigin; Martin Lesser; Yilong Ma; Michael Pourfar; Vijay Dhawan; David Eidelberg
Journal:  Brain       Date:  2007-04-30       Impact factor: 13.501

7.  Posterior cortical brain dysfunction in cognitively impaired patients with Parkinson's disease--a rCBF scintigraphy study.

Authors:  A Wallin; S Ekberg; K Lind; V Milos; A-K Granérus; G Granerus
Journal:  Acta Neurol Scand       Date:  2007-10-10       Impact factor: 3.209

8.  Basal forebrain neurons in the dementia of Parkinson disease.

Authors:  P J Whitehouse; J C Hedreen; C L White; D L Price
Journal:  Ann Neurol       Date:  1983-03       Impact factor: 10.422

9.  SPECT findings in Parkinson's disease associated with dementia.

Authors:  H Sawada; F Udaka; M Kameyama; N Seriu; K Nishinaka; K Shindou; M Kodama; N Nishitani; K Okumiya
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-10       Impact factor: 10.154

10.  Neuropsychological functions and rCBF SPECT in Parkinson's disease patients considered candidates for deep brain stimulation.

Authors:  Anna Paschali; Lambros Messinis; Epameinondas Lyros; Costas Constantoyannis; Zinovia Kefalopoulou; Velissarios Lakiotis; Panagiotis Papathanasopoulos; Paulos Vassilakos
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-05-27       Impact factor: 9.236

View more
  9 in total

Review 1.  Cognitive differences between patients with left-sided and right-sided Parkinson's disease. A review.

Authors:  Nele Verreyt; Gudrun M S Nys; Patrick Santens; Guy Vingerhoets
Journal:  Neuropsychol Rev       Date:  2011-09-29       Impact factor: 7.444

2.  Brain perfusion correlates of cognitive and nigrostriatal functions in de novo Parkinson's disease.

Authors:  Flavio Nobili; Dario Arnaldi; Claudio Campus; Michela Ferrara; Fabrizio De Carli; Andrea Brugnolo; Barbara Dessi; Nicola Girtler; Silvia Morbelli; Giovanni Abruzzese; Gianmario Sambuceti; Guido Rodriguez
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-07-09       Impact factor: 9.236

Review 3.  Role of Neuroimaging on Differentiation of Parkinson's Disease and Its Related Diseases.

Authors:  Toshihide Ogawa; Shinya Fujii; Keita Kuya; Shin-Ichiro Kitao; Yuki Shinohara; Mana Ishibashi; Yoshio Tanabe
Journal:  Yonago Acta Med       Date:  2018-09-26       Impact factor: 1.641

4.  Frontal and posterior subtypes of neuropsychological deficit in Parkinson's disease.

Authors:  Ivy N Miller; Sandy Neargarder; Megan M Risi; Alice Cronin-Golomb
Journal:  Behav Neurosci       Date:  2013-02-11       Impact factor: 1.912

5.  Apolipoprotein E polymorphisms increase the risk of post-stroke depression.

Authors:  Xue-Bin Li; Jie Wang; An-Ding Xu; Jian-Min Huang; Lan-Qing Meng; Rui-Ya Huang; Jun-Li Wang
Journal:  Neural Regen Res       Date:  2016-11       Impact factor: 5.135

6.  Evaluation of 99mTC-ECD SPECT/CT brain Imaging with NeuroGam analysis in Moyamoya disease after surgical revascularization.

Authors:  Jingjing Lou; Zhuang Liu; Bin Xu; Yuan-Kai Wang; Cong-Jin Liu; Miao Liu; Xing-Dang Liu
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.817

7.  Cognitive profiles in Parkinson's disease and their relation to dementia: a data-driven approach.

Authors:  Inga Liepelt-Scarfone; Susanne Gräber; Monika Fruhmann Berger; Anne Feseker; Gülsüm Baysal; Ilona Csoti; Jana Godau; Alexandra Gaenslen; Heiko Huber; Karin Srulijes; Kathrin Brockmann; Daniela Berg
Journal:  Int J Alzheimers Dis       Date:  2012-10-18

8.  NeuroGam Software Analysis in Epilepsy Diagnosis Using 99mTc-ECD Brain Perfusion SPECT Imaging.

Authors:  Peng Fu; Fang Zhang; Jianqing Gao; Jianmin Jing; Liping Pan; Dongxue Li; Lingge Wei
Journal:  Med Sci Monit       Date:  2015-09-20

9.  Effects of acute levodopa challenge on resting cerebral blood flow in Parkinson's Disease patients assessed using pseudo-continuous arterial spin labeling.

Authors:  Yufen Chen; Peter Pressman; Tanya Simuni; Todd B Parrish; Darren R Gitelman
Journal:  PeerJ       Date:  2015-11-03       Impact factor: 2.984

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.